Familial Tumor Syndromes - associated tumors Flashcards
Cowden syndrome
Lhermitte-Duclos disease (LDD)
meningiomas
Tuberous sclerosis complex
subependymal giant cell astrocytoma (SEGA)
Li-Fraumeni Syndrome (5)
Astrocytoma** (most common)
ependymoma
choroid plexus tumors
medulloblastoma
oligodendroglioma
Turcot Syndrome (2)
Medulloblastoma (very high risk for chidhood onset medulloblastoma) MRI q1-3 years in 1st decade
glioblastoma
Nevoid Basal Cell Carcinoma Syndrome (Gorlin)
medulloblastoma
(facial dysmorphism and basal cell carcinoma)
get MRI for medullo up to age 8
VHL
hemangioblastoma
posterior fossa location -most commons
endolymphatic sac tumor
(associated sudden hearing loss and vertigo)
Cowden Syndrome
aka multiple hamartoma syndrome
AD
hamartoma of ectodermal, mesodermal and endodermal origin
(loss of function mut in phosphatase and tensin homolog (PTEN) on chrome 10q23
(now part of PTEN hamartoma tumor syndrome=spectrum)
loss of function -> overgrowth of benign and malignant tumors of breast, follicular thyroid, endometrium, skin, kidneys and GI hamartoma (or ganglioneuroma) colon
clinical manifestation seen by second decade of life (90%)
Cowden syndrome diagnostic criteria
DX: 3 or more major (one must be macrocephaly, LDD or GI hamartomas) -or-
2 major and 3 minor
Major:
cancers: 1-breast, 2-epithelial-endometrial cancer, 3-follicular thyroid cancer, 4-GI hamartomas (incl ganglioneuroma-excludes hyperplastic polyps)
5-Lhermitte- Duclos disease (adults-cerebellar)
6-adult macrocephaly (>97th perc)
7-macular pigmentation of glans penis
8-mult mucocutaneous lesions: 1 trichilemmoma>bx proven; mult. Palmoplantar keratoses; oral papilloma (on tongue and gingiva, multiple; mult cutaneous facial papules
minor: autism, colon cancer, >3 esophageal glycogenic acanthoses, lipomas, MR/ID (IQ<75), papillary thyroid cancer, renal cell carcinoma, single GI hamartoma, testicular lipomatosis, vascular anomalies (mult intracranial dev venous anomalies)
Lhermitte-Duclos Disease
associated with Cowden Syndrome/PTEN (1 of major dx criteria)
slow growing tumor contains dysplastic cells in cerebellum (aka dysplastic gangliocytoma)
classified with neuronal and mixed neuronal-glial tumors
IHC-activation or mTOR pathways (PTEN/AKT/mTOR)
histology: thickened and abnormal myelination of molecular layer in cerebellum, attenuated or absent Purkinje cells, infiltration of granular layer by dysplastic ganglions cells and variable vacuolization white matter)
MRI (imaging of choice) shows striated or laminar appearance of mass. t1-hypotense infrequent contrast
Tuberous Sclerosis Complex
AD
TSC1 or TSC2-form regulatory complex for limiting activity of cell regulators or cell growth mTORcomplex 1 (mTORC1) by inhibiting small GTPase ras homolog
tumors include:
skin (hypomelantoic macules, angiofibromas, fungal fibromas)
brain: subependymal nodules, cortical dysplasia, SEGA
kidneys: angiomyolipomas, cysts, renal cell carcinomas
heart: rhabdomyomas
lungs: lymphangioleiomyomatosis
–
2nd most common neurogenetic tumor syndrome
benign hamartomas of eyes, brain, kidneys, lungs, skin and heart
epilepsy very common
also see neurodevelopmental abnormalities and neurocogntiive deficits
TSC2 has worse burden of disease and outcomes than 1 mut
—
common first manifestations: cardiac rhabdomyoma (in womb), hypopigmented macules, infantile spasms/seizures
—-
TSC Dx Criteria
Major:
Hypomelanotic macules
angiofibromas (3 or more)
ungual fibromas (2 or more)
shagreen patch
retinal hamartomas (2 or more)
cortical tubers
subependymal nodules
cardiac rhabdomyoma
pulmonary lymphangioleiomyoma
angiomyolipomas (2 or more)
Minor:
confetti lesions
dental enamel pits (3 or more)
intraoral fibromas (2 or more)
retinal achromatic patch
multiple renal cysts
nonretinal hamratomas
TSC imaging
cortical tubers, subependymal nodules (usually doesn’t enhance but do calcify)-> if enhance transform into subependymal giant cell astrocytoma. SEGA usually a formal of Monroe and can obstruct flow.
get MRI 1-3 years to age 25
surgery (curative) or everolimus 4.5 mg/m2 median duration is 32.4 months (mtor inhibitor) for growing/progression, after age 25 very slow growing. can monitor
Li-Fraumeni Syndrome
AD / TP53 on chrom 17p13
cancer predisopostion syndrome
high penetrance *>70% men get cancer and >90% women
cancers
adrenocortical carcinoma (50%)
CNS (2-10%)
osteosarcoma (2-3%)
soft-tissue sarcomas (8-9%)
—
CNS tumors occurs before age 40
infiltrating astrocytoma most common
ependymomas
choroid plexus carcinomas
oligodendroglioma
medulloblastoma
supratent primitive neuroectodermal tumors
—-
**40% kids with choroid plexus tumor assoc with LFS
>10% kids with medulloblastoma -shh associated with LFS
—get annual MRIs
Li_fraumeni diagnosis
all three classic criteria germline pathogenic variant TP53 on 17p13
-patient with sarcoma diagnosed before age 45
-1st degree relative with any cancer diagnosis before age 45
-1st or 2nd degree relative with any cancer diagnosis before age 45 or sarcoma dx at any age